WeVote

Bill

Bill

HD 3570

An Act including Krabbe Disease in newborn screening

194th Legislature (2025-2026) Introduced by Colleen Garry

Massachusetts bill mandates newborn screening for Krabbe disease to enable early detection and treatment intervention for this rare, progressive neurological disorder.

0
WeVote Research Nonpartisan
Bill Summary · HD 3570

Legislative bill overview

HD 3570 would mandate that Massachusetts include Krabbe disease in its newborn screening program. Krabbe disease is a rare, inherited metabolic disorder that causes progressive neurological deterioration. The bill would require all newborns in Massachusetts to be tested for this condition at birth.

Why is this important

Early detection of Krabbe disease can enable treatment interventions that may slow or prevent severe neurological damage, potentially preserving quality of life and reducing healthcare costs. Currently, many cases go undetected until symptoms appear, at which point significant irreversible damage has occurred. Adding the test to mandatory screening increases the likelihood of identifying affected infants during the critical window for treatment.

Potential points of contention

  • Cost and resource allocation: Expanding screening programs requires laboratory infrastructure, training, and ongoing funding; some may question whether limited public health resources should prioritize this rare disease over other conditions
  • False positives and anxiety: Newborn screening tests can produce false positives, leading to unnecessary parental anxiety and follow-up procedures; debate exists over acceptable false positive rates
  • Treatment availability: The practical value of early detection depends on whether effective treatments are accessible and whether Massachusetts has adequate specialty care capacity to manage diagnosed cases

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.